XML 39 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Collaborative Research and Development Agreements (Tables)
 3 Months Ended
Mar. 31, 2013
Agreement With Gsk
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under our agreement with GSK (in thousands):

 

     Three months Ended
March  31,		  
     2013      2012  

Initial payment

    $ 357       $ 357   
  

 

 

     

 

 

  
Astra Zeneca
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under our agreement with AstraZeneca (in thousands):

 

     Three Months Ended
March 31,		  
     2013      2012  

Initial payments

    $ 180       $ 180   

Performance of research activities

      346         392   
  

 

 

     

 

 

  

Total

    $ 526       $ 572   
  

 

 

     

 

 

  
National Institutes of Health
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands):

 

     Three Months Ended
March 31,		  
     2013      2012  

NIAID contracts

    $ 598       $ 990   

All other NIH contracts

      162         97   
  

 

 

     

 

 

  

Total grant revenue

    $ 760       $ 1,087